{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:42:21Z","timestamp":1783906941155,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the clinical features and survival outcomes of primary gastrointestinal non-Hodgkin lymphomas (PGINHL) in pediatric and adolescent population, we conducted a population-based cohort study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All pediatric and adolescent patients with PGINHL diagnosed between 2000 and 2019 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Kaplane-Meier estimations were used to generate survival curves based on various criteria. To compare survival curves, the log-rank test was applied. A multivariate Cox proportional hazards model was developed to investigate the effect of each component on overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 334 pediatric and adolescent with PGINHL patients were identified. The median age at diagnosis was 12 years (range 1.0\u201319 years). Tumors were most commonly found in the small bowel (47.3%), followed by the large bowel (42.8%) and the stomach (9.9%). Overall, the most common histological subtype was Burkitt lymphoma (56.9%), followed by diffuse large B-cell lymphoma (DLBCL) (27.8%). Overall survival rates for all patients were 92.2% at 5- year and 91.6% at 10- year, respectively. The Cox proportional hazard regression revealed that only chemotherapy was an important independent predictor in this model. Patients with chemotherapy have a higher survival rate than those without.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study revealed that only chemotherapy was found to be the most important predictor of the OS in pediatric and adolescent PGINHL, providing critical information for therapeutic care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-023-03238-9","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T05:01:44Z","timestamp":1700024504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical characteristics and\u00a0prognostic factors for primary pediatric and adolescent Non-Hodgkin Lymphomas of the gastrointestinal tract: a population-based study"],"prefix":"10.1186","volume":"21","author":[{"given":"Peng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"1","key":"3238_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/j.sempedsurg.2005.11.007","volume":"15","author":"AP Ladd","year":"2006","unstructured":"Ladd AP, Grosfeld JL. Gastrointestinal tumors in children and adolescents. Semin Pediatr Surg. 2006;15(1):37\u201347.","journal-title":"Semin Pediatr Surg"},{"issue":"4","key":"3238_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.rcl.2016.03.004","volume":"54","author":"EM Chung","year":"2016","unstructured":"Chung EM, Pavio M. Pediatric extranodal lymphoma. Radiol Clin North Am. 2016;54(4):727\u201346.","journal-title":"Radiol Clin North Am"},{"issue":"11","key":"3238_CR3","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.21873\/anticanres.13855","volume":"39","author":"B Naeem","year":"2019","unstructured":"Naeem B, Ayub A. Primary Pediatric Non-Hodgkin Lymphomas of the Gastrointestinal Tract: A Population-based Analysis. Anticancer Res. 2019;39(11):6413\u20136.","journal-title":"Anticancer Res"},{"issue":"8","key":"3238_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/08880018.2020.1779884","volume":"37","author":"N Kurucu","year":"2020","unstructured":"Kurucu N, Aky\u00fcz C, Yal\u00e7\u0131n B, et al. Primary gastric lymphoma: A report of 16 pediatric cases treated at a single institute and review of the literature. Pediatr Hematol Oncol. 2020;37(8):656\u201364.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"3238_CR5","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/MPH.0b013e3181ef0402","volume":"33","author":"G Gupta","year":"2011","unstructured":"Gupta G, Agarwala S, Thulkar S, et al. Jejunal stricture: a rare complication of chemotherapy in pediatric gastrointestinal B-cell non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2011;33(2):e69-71.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"3238_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2141.2006.06444.x","volume":"136","author":"PF Ferrucci","year":"2007","unstructured":"Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years. Br J Hematol. 2007;136(4):521\u201338.","journal-title":"Br J Hematol"},{"issue":"6","key":"3238_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s11605-016-3129-8","volume":"20","author":"EM Shannon","year":"2016","unstructured":"Shannon EM, MacQueen IT, Miller JM, et al. Management of primary gastrointestinal lymphomas: a population based survival analysis. J Gastrointest Surg. 2016;20(6):1141\u20139.","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"3238_CR8","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.jpedsurg.2011.06.006","volume":"46","author":"N Kassira","year":"2011","unstructured":"Kassira N, Pedroso FE, Cheung MC, et al. Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from the SEER registry. J Pediatr Surg. 2011;46(10):1956\u201364.","journal-title":"J Pediatr Surg"},{"issue":"4","key":"3238_CR9","first-page":"251","volume":"17","author":"A Morsi","year":"2005","unstructured":"Morsi A, Abd El-Ghani Ael-G, El-Shafiey M, et al. Clinico-pathological features and outcome of management of pediatric gastrointestinal lymphoma. J Egypt Natl Canc Inst. 2005;17(4):251\u20139.","journal-title":"J Egypt Natl Canc Inst."},{"issue":"2","key":"3238_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archsurg.1990.01410140130021","volume":"125","author":"ID Fleming","year":"1990","unstructured":"Fleming ID, Turk PS, Murphy SB, et al. Surgical implications of primary gastrointestinal lymphoma of childhood. Arch Surg. 1990;125(2):252\u20136.","journal-title":"Arch Surg"},{"issue":"2","key":"3238_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0022-3468(92)90318-2","volume":"27","author":"MP LaQuaglia","year":"1992","unstructured":"LaQuaglia MP, Stolar CJ, Krailo M, et al. The role of surgery in abdominal non-Hodgkin\u2019s lymphoma: experience from the Childrens Cancer Study Group. J Pediatr Surg. 1992;27(2):230\u20135.","journal-title":"J Pediatr Surg"},{"issue":"10","key":"3238_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/0022-3468(91)90341-P","volume":"26","author":"MC Stovroff","year":"1991","unstructured":"Stovroff MC, Coran AG, Hutchinson RJ. The role of surgery in American Burkitt\u2019s lymphoma in children. J Pediatr Surg. 1991;26(10):1235\u20138.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"3238_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0022-3468(92)90319-3","volume":"27","author":"RC Shamberger","year":"1992","unstructured":"Shamberger RC, Weinstein HJ. The role of surgery in abdominal Burkitt\u2019s lymphoma. J Pediatr Surg. 1992;27(2):236\u201340.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"3238_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ssu.2980090613","volume":"9","author":"JL Ternberg","year":"1993","unstructured":"Ternberg JL. Changing role of surgery in childhood lymphomas. Semin Surg Oncol. 1993;9(6):541\u20134.","journal-title":"Semin Surg Oncol"},{"issue":"2","key":"3238_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.suc.2016.11.012","volume":"97","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Badgwell BD, Mansfield PF. Multimodality treatment of gastric lymphoma. Surg Clin North Am. 2017;97(2):405\u201320.","journal-title":"Surg Clin North Am"},{"issue":"7","key":"3238_CR16","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109(7):2773\u201380.","journal-title":"Blood"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03238-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T05:03:02Z","timestamp":1700024582000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03238-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3238"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03238-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}